Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
12
86%
Ph phase_4
1
7%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
12(92.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(12)
Terminated(1)
Other(1)

Detailed Status

Completed12
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (7.7%)
N/A12 (92.3%)

Trials by Status

completed1286%
unknown17%
withdrawn17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14